SCHEMBL30416633

SCHEMBL30416633

CCOc1cncc(-c2ccc(NC(=O)C(OC)c3cncc(Cl)n3)nc2)n1

nearest known ligand 0.49

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CTPS1 P17812 20/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22924778 1.00 CTPS1 (0.49) CTPS1
SCHEMBL30528892 0.82 CTPS1 (0.61) CTPS1
SCHEMBL21381516 0.82 CTPS1 (0.61) CTPS1
SCHEMBL29791336 0.79 CTPS1 (0.52) CTPS1
SCHEMBL31515050 0.76 CTPS1 (0.49) CTPS1
SCHEMBL21392170 0.76 CTPS1 (0.49) CTPS1
SCHEMBL22491790 0.76 CTPS1 (0.55) CTPS1
SCHEMBL30528990 0.76 CTPS1 (0.55) CTPS1
SCHEMBL22924964 0.75 CTPS1 (0.77) CTPS1
SCHEMBL30416376 0.75 CTPS1 (0.77) CTPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192673-A1 Compounds STEP PHARMA S.A.S. (FR) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192673-A1 Compounds CYP1A1, UGT1A1, CYP1A2 CTPS1 2586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.